Study guide
2.1 DSM-5-TR Diagnostic Criteria & Severity Continuum
IC&RC Advanced Alcohol & Drug Counselor AADC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Master's-Level Credentialing
1.1 IC&RC AADC Exam Purpose, Structure & Scoring 1.2 Master's-Level Preparation Strategy & Exam Blueprint Navigation
2 Chapter 2: Diagnostic Systems & DSM-5-TR Substance Use Disorders
2.1 DSM-5-TR Diagnostic Criteria & Severity Continuum 2.2 Substance Classes, Intoxication & Withdrawal Syndromes 2.3 Neurobiology of Addiction & Tolerance Mechanics
3 Chapter 3: Standardized Screening, Comprehensive Assessment & Diagnostic Feedback
3.1 Clinical Distinctions Between Screening and Assessment 3.2 Evidence-Based Assessment Instruments 3.3 Selecting Culturally Appropriate Screening and Assessment Tools 3.4 Biopsychosocial Intake Interviewing & Stage-of-Change Assessment 3.5 Documenting Screening and Assessment Results 3.6 Discussing Diagnostic Results and Recommendations
4 Chapter 4: Complex Co-Occurring Psychiatric Disorders & Differential Diagnosis
4.1 Differential Diagnosis Principles: Primary vs Substance-Induced Disorders 4.2 Co-Occurring Depressive, Bipolar & Anxiety Disorders 4.3 Personality Disorders, PTSD & Severe Mental Illness
5 Chapter 5: Trauma, Suicide Risk & Crisis Engagement
5.1 Trauma Assessment & Complex Post-Traumatic Stress 5.2 Lethality & Suicide Risk Formulation 5.3 Crisis Intervention & Motivational Engagement
6 Chapter 6: ASAM Criteria & Multidimensional Level of Care Placement
6.1 ASAM Six Assessment Dimensions 6.2 ASAM Continuum of Care Levels 6.3 Level-of-Care Transitions, Continued Stay & Discharge
7 Chapter 7: Treatment Planning & SMART Goal Formulation
7.1 Problem Identification & Clinical Formulation 7.2 SMART Goals, Objectives & Interventions 7.3 Treatment Plan Evolution, Ongoing Review & Documentation 7.4 Educating the Person Served About the Counseling Process
8 Chapter 8: Pharmacotherapy & Medications for Substance Use Disorders
8.1 Medications for Opioid Use Disorder (MOUD) 8.2 Medications for Alcohol and Tobacco Use Disorders 8.3 Psychiatric Pharmacotherapy & The Counselor's Role
9 Chapter 9: Interprofessional Collaboration, Care Coordination & Referral
9.1 Multidisciplinary Teamwork & Integrated Healthcare 9.2 Referral Processes & Continuity of Care 9.3 Coordination with Specialized Systems
10 Chapter 10: Cognitive Behavioral Therapy & Relapse Prevention
10.1 Theoretical Foundations of CBT in Addiction 10.2 Cognitive Restructuring & Behavioral Coping Skills 10.3 Relapse Prevention Models & The Abstinence Violation Effect 10.4 Community Reinforcement & Third-Wave CBT Approaches
11 Chapter 11: Motivational Interviewing & Motivational Enhancement Therapy
11.1 Spirit & Foundational Principles of Motivational Interviewing 11.2 Four Processes & OARS Core Clinical Skills 11.3 Motivational Enhancement Therapy Protocol & Change Talk
12 Chapter 12: Contingency Management, Twelve-Step Facilitation & Third-Wave Behavioral Approaches
12.1 Operant Conditioning & Contingency Management Protocols 12.2 Twelve-Step Facilitation (TSF) Therapy 12.3 Mindfulness-Based Relapse Prevention (MBRP) & Acceptance Approaches 12.4 Multiple Pathways of Recovery & Adapting Intervention Strategies
13 Chapter 13: Family Systems, Adolescent Considerations & Group Psychotherapy
13.1 Family Systems Approaches in Addiction Treatment 13.2 Adolescent-Specific Assessment & Evidence-Based Interventions 13.3 Group Psychotherapy Dynamics & Facilitation
14 Chapter 14: Psychoeducation, Health Promotion & Infectious Disease
14.1 Medical & Health Consequences of Chronic Substance Use 14.2 Infectious Diseases: HIV/AIDS, Viral Hepatitis & STI Transmission 14.3 Wellness, Lifestyle Modification & Holistic Recovery Support
15 Chapter 15: Confidentiality, 42 CFR Part 2 & Legal Mandates
15.1 Federal Confidentiality Laws: 42 CFR Part 2 Foundations 15.2 Comparing 42 CFR Part 2 and HIPAA: Consent & Disclosures 15.3 Medical Emergencies, Child/Elder Abuse & Mandated Reporting 15.4 Duty to Warn (Tarasoff) & Responding to Subpoenas and Court Orders
16 Chapter 16: Clinical Supervision Models, Competency Evaluation & Gatekeeping
16.1 Theoretical Frameworks & Models of Clinical Supervision 16.2 The Supervisory Relationship, Roles & Modalities 16.3 Competency Evaluation, Formative Feedback & Gatekeeping 16.4 Vicarious Liability, Legal Risks & Managing Impaired Counselors
17 Chapter 17: Professional Ethics, Boundaries & Multicultural Competence
17.1 Professional Codes of Ethics & Ethical Decision-Making Frameworks 17.2 Dual Relationships, Professional Boundaries & Conflict of Interest 17.3 Multicultural Competence, Cultural Humility & Health Disparities 17.4 Technology, Telehealth & Digital Ethics in Addiction Counseling 17.5 Integrating Research Into Clinical Practice
2.1 DSM-5-TR Diagnostic Criteria & Severity Continuum
Key Takeaways Explain This Topic AI
DSM-5-TR replaces the categorical dichotomy of substance abuse versus dependence with a unified, unidimensional Substance Use Disorder (SUD) continuum graded by 11 operational criteria into Mild (2–3), Moderate (4–5), and Severe (6+) presentations.
The 11 diagnostic criteria are systematically organized across four functional clusters: Impaired Control (Criteria 1–4), Social Impairment (Criteria 5–7), Risky Use (Criteria 8–9), and Pharmacological Criteria (Criteria 10–11).
Under the mandatory Prescribed Medication Rule, Criteria 10 (Tolerance) and 11 (Withdrawal) are explicitly excluded from diagnostic counting when medications are taken strictly under appropriate medical supervision.
Criterion 4 (Craving) was introduced in DSM-5 to capture neurobiological incentive salience and cue-reactivity, replacing the psychometrically flawed and socioeconomically biased recurrent legal problems criterion.
Clinical course specifiers define recovery stages: In Early Remission requires 3 to 12 continuous months without meeting any criteria (except Criterion 4: Craving), whereas In Sustained Remission requires 12 or more continuous months.
Last updated: September 2026
2.1 DSM-5-TR Diagnostic Criteria & Severity Continuum
Note
The Evolution to a Dimensional Continuum : In the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), Substance Use Disorders (SUD) are conceptualized as a single, unidimensional continuum of pathology rather than discrete categorical states. Master's-level clinicians must demonstrate acute diagnostic precision: identifying the 11 operational criteria across four functional clusters, navigating clinical specifiers, and applying the prescribed medication rule to differentiate physiological adaptation from addictive disease.
Historical Evolution: Deconstructing the DSM-IV-TR Dichotomy
For nearly two decades under the DSM-IV and DSM-IV-TR, clinical addiction practice was organized around an artificial, categorical distinction between Substance Abuse and Substance Dependence . Substance abuse was conceptualized as an early, milder, non-physiological pattern of maladaptive use characterized primarily by external psychosocial, legal, or occupational fallout. In contrast, substance dependence was conceptualized as an advanced, severe categorical state requiring physiological neuroadaptation (tolerance or withdrawal) or compulsive behavioral patterns.
Extensive epidemiological research and item-response theory (IRT) analyses exposed severe structural and psychometric flaws in this binary framework:
The Problem of "Diagnostic Orphans" : Individuals who endorsed two dependence criteria (such as tolerance and spending excessive time obtaining substances) but zero abuse criteria could not receive any formal DSM-IV diagnosis. Despite experiencing profound clinical impairment, these clients were termed diagnostic orphans and frequently denied insurance authorization for evidence-based addiction treatment.
Poor Psychometric Hierarchy : Clinical trials demonstrated that abuse and dependence did not represent distinct qualitative syndromes. Instead, symptoms fell along a single, continuous latent trait of severity, where certain "abuse" symptoms (e.g., hazardous driving) occurred at lower thresholds than some "dependence" symptoms.
Elimination of the Legal Problems Criterion : Under DSM-IV, recurrent substance-related legal encounters (e.g., arrests for disorderly conduct or possession) constituted a primary abuse criterion. Psychometric audits revealed that this criterion lacked internal consistency and was heavily confounded by racial profiling, socioeconomic disparities, and regional variations in law enforcement practices rather than underlying psychiatric pathology.
Addition of Criterion 4 (Craving) : Grounded in contemporary neurobiology and incentive salience theory, craving reflects conditioned mesocorticolimbic cue-reactivity. Its inclusion anchored diagnosis in an intrinsic neurobiological hallmark of addiction that strongly predicts clinical relapse.
Under DSM-5-TR, an SUD diagnosis is established when a cluster of cognitive, behavioral, and physiological symptoms demonstrates that the individual continues substance consumption despite significant substance-related problems occurring within a 12-month period .
The 11 Diagnostic Criteria Across Four Functional Clusters
The 11 diagnostic criteria are systematically categorized into four biopsychosocial domains: +--------------------------------------------------------------------------------+
- | The 11 DSM-5-TR Substance Use Disorder Criteria |
- +--------------------------------------------------------------------------------+
- | Impaired Control | 1. Larger amounts / longer duration than intended |
- | | 2. Persistent desire / unsuccessful efforts to cut down |
- | | 3. Great deal of time spent obtaining, using, recovering|
- | | 4. Craving, or strong desire / urge to use |
- +----------------------+---------------------------------------------------------+
- | Social Impairment | 5. Failure to fulfill major role obligations |
- | | 6. Continued use despite persistent social problems |
- | | 7. Important activities given up or reduced |
- +----------------------+---------------------------------------------------------+
- | Risky Use | 8. Recurrent use in physically hazardous situations |
- | | 9. Continued use despite physical / psychological harm |
- +----------------------+---------------------------------------------------------+
- | Pharmacological | 10. Tolerance (markedly increased amount / less effect) |
- | | 11. Withdrawal (characteristic syndrome / relief use) |
- +--------------------------------------------------------------------------------+
- Advanced Clinical Nuances of Each Criterion
Functional Cluster Criterion # DSM-5-TR Operational Description Master's-Level Clinical Assessment Nuance
Impaired Control 1 Substance taken in larger amounts or over a longer duration than originally intended. Reflects executive dysregulation and loss of volitional termination once consumption begins (e.g., planning to have one drink but continuing to severe intoxication).
2 Persistent desire or unsuccessful efforts to cut down or control substance use. Client articulates repeated failed self-imposed control strategies (e.g., switching from liquor to beer, limiting drinking to weekends only, making pacts with spouses).
3 Great deal of time spent in activities necessary to obtain, use, or recover from substance effects. Daily scheduling, cognitive bandwidth, and financial resources are subordinated to procurement, consumption, or protracted physical/emotional recovery.
4 Craving, or a strong desire or urge to use the substance. Classical Pavlovian cue-reactivity; intense conditioned visceral urges evoked by internal negative affect, environmental paraphernalia, or drug-associated settings.
Social Impairment 5 Recurrent use resulting in failure to fulfill major role obligations at work, school, or home. Manifests as chronic absenteeism, disciplinary probation, academic failure, domestic neglect, or child-care impairment directly attributable to substance use.
6 Continued substance use despite persistent or recurrent social or interpersonal problems. Marital discord, domestic conflict, estrangement, or physical altercations caused or exacerbated by intoxication, emotional withdrawal, or erratic behavioral changes.
7 Important social, occupational, or recreational activities given up or reduced. Progressive behavioral narrowing; client systematically abandons athletics, family traditions, and creative hobbies to prioritize substance procurement and use.
Risky Use 8 Recurrent substance use in situations in which it is physically hazardous. Operating motor vehicles or machinery while intoxicated, combining central nervous system depressants, or engaging in unsafe activities while impaired.
9 Continued use despite knowledge of having a persistent physical or psychological problem. Consuming alcohol despite documented liver cirrhosis or esophageal varices; using stimulants despite uncontrolled malignant hypertension; using cannabis despite panic attacks.
Pharmacological 10 Tolerance: (a) Need for markedly increased amounts, or (b) markedly diminished effect with same amount. Neuroadaptive down-regulation or desensitization of postsynaptic receptors, or accelerated hepatic metabolic clearance.
11 Withdrawal: (a) Characteristic withdrawal syndrome, or (b) substance taken to relieve or avoid withdrawal. Rebound neurochemical excitability or autonomic storm following cessation; consuming the substance or a related agent (e.g., morning drink) to stave off withdrawal distress.
The Prescribed Medication Rule: Physical Dependence vs. Addiction
A critical diagnostic trap on the IC&RC AADC examination involves the clinical boundary between physiological neuroadaptation and the compulsive pathology of an addictive disorder:
Important
The Mandatory Prescribed Medication Exception : DSM-5-TR explicitly mandates that Criterion 10 (Tolerance) and Criterion 11 (Withdrawal) are NOT considered to be met for individuals taking prescribed medications (such as opioid analgesics, benzodiazepines, stimulants, or sedative-hypnotics) strictly under appropriate medical supervision.
Clinical Case Analysis: Physiological Dependence vs. Substance Use Disorder
Consider an adult patient with severe chronic neuropathic pain who has taken prescribed extended-release oxycodone 20 mg twice daily exactly as directed by a pain specialist for five years. The patient exhibits neuroadaptive tolerance and experiences diaphoresis, rhinorrhea, nausea, and tremors if a dose is unexpectedly delayed. However, the patient never takes additional doses, does not obsessively crave the medication, maintains excellent vocational and family functioning, and engages in no hazardous use:
Flawed Entry-Level Clinical Assessment : Diagnosing "Mild Opioid Use Disorder" by incorrectly counting Tolerance (Criterion 10) and Withdrawal (Criterion 11) as two criteria.
Correct Master's-Level Determination : No Substance Use Disorder . Physical dependence is a predictable biological adaptation to continuous receptor agonism. Because the medication is taken strictly under medical supervision and no criteria from Impaired Control, Social Impairment, or Risky Use are present, the valid criterion count is zero.
When the Exception Ceases to Apply : If this patient begins taking additional unauthorized doses to self-treat emotional distress, "doctor shops" across multiple clinics, obtains illicit diversion pills, or alters the route of administration (e.g., crushing tablets for insufflation), the clinician must evaluate all 11 criteria —including tolerance and withdrawal.
Severity Continuum & The 12-Month Diagnostic Window
DSM-5-TR establishes diagnostic severity by summing the total number of positive criteria documented over the preceding 12-month period :
Severity Tier Criteria Threshold Clinical Presentation Profile Standard Level of Care Placement (ASAM)
Subthreshold (Hazardous Use) 1 Criterion Does not meet formal SUD criteria; represents risky or hazardous use requiring early screening and intervention. ASAM Level 0.5 (Early Intervention / SBIRT)
Mild SUD 2 to 3 Criteria Early or localized impairment, often confined to one or two functional clusters (e.g., hazardous use and unsuccessful cut-down efforts). ASAM Level 1.0 (Outpatient Counseling)
Moderate SUD 4 to 5 Criteria Multifaceted impairment spanning multiple clusters; noticeable vocational, social, or physiological consequences. ASAM Level 2.1 (Intensive Outpatient) or 2.5 (Partial Hospitalization)
Severe SUD 6 or More Criteria Pervasive executive, social, risky, and pharmacological deterioration; compulsive seeking dominates daily existence. ASAM Level 3.1–3.7 (Residential) or 4.0 (Medically Managed Inpatient)
Tip
Pacing the Diagnostic Interview : Clinicians must rigorously evaluate every criterion individually across the full 12-month timeline. Symptoms occurring outside the 12-month window reflect historical pathology but cannot be counted toward active diagnostic severity.
Clinical Course Specifiers & Remission Architecture
Once an SUD diagnosis is established, DSM-5-TR utilizes specific clinical course specifiers to capture the trajectory of recovery and therapeutic context:
Course Specifier Diagnostic Operational Definition Master's-Level Clinical Nuance
In Early Remission At least 3 months but less than 12 months without meeting any criteria for Substance Use Disorder (except Criterion 4: Craving). Highly vulnerable period for relapse; requires intense recovery support, cognitive restructuring, and relapse prevention planning.
In Sustained Remission 12 continuous months or longer without meeting any criteria for Substance Use Disorder (except Criterion 4: Craving). Reflects stabilized behavioral recovery; neuroplastic consolidation and frontostriatal circuit healing.
On Maintenance Therapy The individual is taking an approved prescription maintenance medication (e.g., methadone, buprenorphine, naltrexone for OUD; nicotine replacement therapy). Client meets no criteria for that substance class, except tolerance to or withdrawal from the maintenance agent.
In a Controlled Environment The individual is residing in an environment where access to alcohol and controlled substances is physically restricted (e.g., locked inpatient unit, correctional facility). Prevents conflating institutional restriction with autonomous, internalized recovery self-efficacy.
The Craving Exception in Remission
A critical examination point is the Craving Exception : Criterion 4 (Craving) is the only diagnostic criterion that is permitted to persist during both Early Remission and Sustained Remission without invalidating the remission status. Conditioned cue-reactivity, stress-induced glutamate surges, and neuroplastic memory traces can provoke subjective cravings years into continuous abstinence. As long as no other criteria are met, the client remains fully in remission.
Clinical Decision Framework for Multi-Substance Presentations
In master's-level clinical practice, clients rarely present with single-substance pathology. DSM-5-TR eliminated the legacy DSM-IV category of "Polysubstance Dependence":
Independent Substance Formulation : Clinicians must independently evaluate and assign a distinct DSM-5-TR diagnosis and severity rating for each specific psychoactive substance class consumed (e.g., Severe Cocaine Use Disorder, Moderate Alcohol Use Disorder, and Mild Cannabis Use Disorder ).
Timeline Disaggregation : Each substance use disorder must be evaluated across its own distinct 12-month timeline, accounting for differing onset dates, remission statuses, and withdrawal presentations.
Toxicological Verification vs. Self-Report : Advanced counselors must integrate collateral reports, prescription drug monitoring program (PDMP) data, and longitudinal urine drug screen (UDS) results to reconcile discrepancies between subjective client reporting and objective biomarker evidence.